Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000936753-14-000076
Filing Date
2014-02-14
Accepted
2014-02-14 10:29:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC13GA CUMBERLAND PHARMACEUTICALS DEC13 cpix.txt SC 13G/A 7004
  Complete submission text file 0000936753-14-000076.txt   8696
Mailing Address 200 EAST RANDOLPH DRIVE SUITE 2900 CHICAGO IL 60601
Business Address 200 EAST RANDOLPH DRIVE SUITE 2900 CHICAGO IL 60601 (312) 726-0140
ARIEL INVESTMENTS, LLC (Filed by) CIK: 0000936753 (see all company filings)

EIN.: 020712418 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-85205 | Film No.: 14612045
SIC: 2834 Pharmaceutical Preparations